ANAPTYSBIO INC (ANAB)
US0327241065 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 53.70M | 35.97M | 71.30M | 495.70M | 250.50M | |||
| Marketable Securities | 300.97M | 354.94M | 369.90M | 52.40M | 143.20M | |||
| Receivables | 7.09M | 6.85M | 1.40M | 900.00K | N/A | |||
| Other Current Assets | 10.67M | 9.08M | 4.50M | 4.90M | 2.90M | |||
| Total Current Assets | 372.42M | 406.83M | 447.20M | 553.90M | 396.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 17.69M | 18.27M | 20.00M | 21.80M | 2.10M | |||
| Investments And Advances | 15.47M | 27.03M | 142.90M | 67.10M | 17.50M | |||
| Other Non-Current Assets | 256.00K | 256.00K | 300.00K | 300.00K | 300.00K | |||
| Total Non-Current Assets | 33.41M | 45.55M | 163.20M | 89.20M | 20.00M | |||
| TOTAL ASSETS | 405.83M | 452.39M | 610.40M | 643.10M | 416.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 27.72M | 32.74M | 23.30M | 14.40M | 15.60M | |||
| Accounts Payable | 4.58M | 4.70M | 2.80M | 1.70M | 4.20M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 32.30M | 37.44M | 26.10M | 16.10M | 19.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 325.76M | 326.84M | 322.20M | 270.50M | 0.00 | |||
| Total Non-Current Liabilities | 325.76M | 326.84M | 322.20M | 270.50M | 0.00 | |||
| TOTAL LIABILITIES | 358.06M | 364.29M | 348.30M | 286.60M | 19.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -658.03M | -614.10M | -450.50M | -321.80M | -264.00M | |||
| Additional Paid In Capital | 706.41M | 702.97M | 717.80M | 678.60M | 660.70M | |||
| Common Shares | 27.00K | 27.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -624.00K | -797.00K | -5.20M | -400.00K | 0.00 | |||
| Shares Outstanding | 27.32M | 26.60M | 28.50M | 27.60M | 27.40M | |||
| Tangible Book Value per Share | 1.75 | 3.31 | 9.20 | 12.91 | 14.48 | |||
| Total Shareholders' Equity | 47.78M | 88.10M | 262.10M | 356.40M | 396.70M | |||
| TOTAL LIABILITIES AND EQUITY | 405.83M | 452.39M | 610.40M | 643.10M | 416.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 11.53 | 10.87 | 17.13 | 34.40 | 20.03 | |||
| Return On Assets (ROA) | -40.24% | -36.17% | -21.09% | -8.99% | -4.78% | |||
| Return On Equity (ROE) | -341.80% | -185.71% | -49.11% | -16.22% | -5.02% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD